142 related articles for article (PubMed ID: 16904309)
1. Chemiluminescent optical fiber immunosensor for detection of autoantibodies to ovarian and breast cancer-associated antigens.
Salama O; Herrmann S; Tziknovsky A; Piura B; Meirovich M; Trakht I; Reed B; Lobel LI; Marks RS
Biosens Bioelectron; 2007 Feb; 22(7):1508-16. PubMed ID: 16904309
[TBL] [Abstract][Full Text] [Related]
2. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.
Yagihashi A; Ohmura T; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Hirata K; Watanabe N
Clin Chim Acta; 2005 Dec; 362(1-2):125-30. PubMed ID: 16026775
[TBL] [Abstract][Full Text] [Related]
3. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.
Gagnon A; Kim JH; Schorge JO; Ye B; Liu B; Hasselblatt K; Welch WR; Bandera CA; Mok SC
Clin Cancer Res; 2008 Feb; 14(3):764-71. PubMed ID: 18245537
[TBL] [Abstract][Full Text] [Related]
4. (Auto)antibodies in human breast cancer sera against antigens associated with breast cancer cells, detected by immunoblotting.
Ronai Z; Sulitzeanu D
J Natl Cancer Inst; 1986 Dec; 77(6):1203-9. PubMed ID: 3540417
[TBL] [Abstract][Full Text] [Related]
5. Immobilization strategies of Brucella particles on optical fibers for use in chemiluminescence immunosensors.
Liebes Y; Amir L; Marks RS; Banai M
Talanta; 2009 Nov; 80(1):338-45. PubMed ID: 19782234
[TBL] [Abstract][Full Text] [Related]
6. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor and anti-ovarian autoantibodies in women with ovarian cancer.
Barua A; Bradaric MJ; Kebede T; Espionosa S; Edassery SL; Bitterman P; Rotmensch J; Luborsky JL
Am J Reprod Immunol; 2007 Apr; 57(4):243-9. PubMed ID: 17362385
[TBL] [Abstract][Full Text] [Related]
8. Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer.
Lokshin AE; Winans M; Landsittel D; Marrangoni AM; Velikokhatnaya L; Modugno F; Nolen BM; Gorelik E
Gynecol Oncol; 2006 Aug; 102(2):244-51. PubMed ID: 16434085
[TBL] [Abstract][Full Text] [Related]
9. Optical fiber immunosensor based on a poly(pyrrole-benzophenone) film for the detection of antibodies to viral antigen.
Konry T; Novoa A; Shemer-Avni Y; Hanuka N; Cosnier S; Lepellec A; Marks RS
Anal Chem; 2005 Mar; 77(6):1771-9. PubMed ID: 15762584
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer.
Kim S; Cho H; Nam EJ; Kim SW; Kim YT; Park YW; Kim BW; Kim JH
Genes Chromosomes Cancer; 2010 Jul; 49(7):585-95. PubMed ID: 20461751
[TBL] [Abstract][Full Text] [Related]
11. Chemiluminescent optical fiber immunosensor for the detection of anti-West Nile virus IgG.
Herrmann S; Leshem B; Landes S; Rager-Zisman B; Marks RS
Talanta; 2005 Mar; 66(1):6-14. PubMed ID: 18969954
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
Fernández Madrid F
Cancer Lett; 2005 Dec; 230(2):187-98. PubMed ID: 16297705
[TBL] [Abstract][Full Text] [Related]
13. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
[TBL] [Abstract][Full Text] [Related]
14. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ.
Desmetz C; Bibeau F; Boissière F; Bellet V; Rouanet P; Maudelonde T; Mangé A; Solassol J
J Proteome Res; 2008 Sep; 7(9):3830-7. PubMed ID: 18683965
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody profiles as biomarkers of breast cancer.
Tabernero MD; Lv LL; Anderson KS
Cancer Biomark; 2010; 6(5-6):247-56. PubMed ID: 20938085
[TBL] [Abstract][Full Text] [Related]
16. Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.
López-Árias E; Aguilar-Lemarroy A; Felipe Jave-Suárez L; Morgan-Villela G; Mariscal-Ramírez I; Martínez-Velázquez M; Alvarez AH; Gutiérrez-Ortega A; Hernández-Gutiérrez R
Electrophoresis; 2012 Jul; 33(14):2130-7. PubMed ID: 22821488
[TBL] [Abstract][Full Text] [Related]
17. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
Lu H; Goodell V; Disis ML
J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901
[TBL] [Abstract][Full Text] [Related]
18. Serum antibodies to lipophilin B detected in late stage breast cancer patients.
Carter D; Dillon DC; Reynolds LD; Retter MW; Fanger G; Molesh DA; Sleath PR; McNeill PD; Vedvick TS; Reed SG; Persing DH; Houghton RL
Clin Cancer Res; 2003 Feb; 9(2):749-54. PubMed ID: 12576445
[TBL] [Abstract][Full Text] [Related]
19. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
[TBL] [Abstract][Full Text] [Related]
20. Human kallikrein 10 ELISA development and validation in breast cancer sera.
Ewan King L; Li X; Cheikh Saad Bouh K; Pedneault M; Chu CW
Clin Biochem; 2007 Sep; 40(13-14):1057-62. PubMed ID: 17585892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
